These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8505883
1. [Study of antibiotic sensitivity of Streptococcus pyogenes isolated in the hospital milieu (Charles Nicolle hospital of Tunis)]. el Bour M, Fendri C, Ben Hassen A, Kamoun A, Boudabbous A, Ben Redjeb S. Med Trop (Mars); 1993; 53(1):13-7. PubMed ID: 8505883 [Abstract] [Full Text] [Related]
2. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries. Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA. Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986 [Abstract] [Full Text] [Related]
3. [Antimicrobial susceptibility of Streptococcus agalactiae strains in Monastir]. Sahnoun O, Ben Abdallah H, Noomen S, Ben Elhadj Khélifa A, Mastouri M. Med Mal Infect; 2007 Nov; 37(11):734-7. PubMed ID: 17459635 [Abstract] [Full Text] [Related]
4. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains]. Prado V, Romero J, Herrera N, Marinkovic K, Bustos R. Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116 [Abstract] [Full Text] [Related]
5. [Emergence of resistance to macrolides in Streptococcus pyogenes]. Vinagre C, Cifuentes M, Valdivieso F, Ojeda A, Prado V. Rev Med Chil; 1999 Dec; 127(12):1447-52. PubMed ID: 10835751 [Abstract] [Full Text] [Related]
6. Molecular mechanisms of tetracycline and macrolide resistance and emm characterization of Streptococcus pyogenes isolates in Tunisia. Hraoui M, Boutiba-Ben Boubaker I, Doloy A, Ben Redjeb S, Bouvet A. Microb Drug Resist; 2011 Sep; 17(3):377-82. PubMed ID: 21612508 [Abstract] [Full Text] [Related]
7. [Occurrence and susceptibility to antibiotics of Streptococcus pyogenes strains from purulent infections in soft tissues]. Kania I, Gospodarek E, Ulatowska B. Pol Merkur Lekarski; 2000 Oct; 9(52):684-6. PubMed ID: 11144057 [Abstract] [Full Text] [Related]
8. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. Szczypa K, Sadowy E, Izdebski R, Hryniewicz W. J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367 [Abstract] [Full Text] [Related]
9. [Antimicrobial resistance characteristics of clinical isolates of Streptococcus pyogenes]. Rodríguez RS, Calderón-Jaimes E, Gómez-Barreto D, Espinosa-de los Monteros LE. Salud Publica Mex; 2000 Oct; 42(3):226-9. PubMed ID: 10929504 [Abstract] [Full Text] [Related]
10. [Occurrence and drug-resistance of beta-hemolytic streptococci]. Mikołajczyk D, Budzyńska A, Kaczmarek A, Gospodarek E. Med Dosw Mikrobiol; 2007 Oct; 59(4):301-7. PubMed ID: 18416122 [Abstract] [Full Text] [Related]
11. [Antibiotic sensitivity of strains of group A beta-hemolytic streptococci isolated recently]. Alós JI, González-Palacios R, Cuadros JA, Escobar JC. Med Clin (Barc); 1990 Jan 13; 94(1):12-4. PubMed ID: 2186225 [Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W, Georgopoulos A. Int J Antimicrob Agents; 2004 Sep 13; 24(3):290-3. PubMed ID: 15325435 [Abstract] [Full Text] [Related]
13. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program. Gracia M, Díaz C, Coronel P, Gimeno M, García-Rodas R, Rodríguez-Cerrato V, del Prado G, Huelves L, Ruiz V, Naves PF, Ponte MC, Granizo JJ, Soriano F. Diagn Microbiol Infect Dis; 2009 May 13; 64(1):52-6. PubMed ID: 19232860 [Abstract] [Full Text] [Related]
14. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus. Koliou M, Ioannou Y, Efstratiou A, Hannidou N, Pieri V, Alexandrou M, Soteriades ES. Clin Microbiol Infect; 2007 Jun 13; 13(6):645-7. PubMed ID: 17378928 [Abstract] [Full Text] [Related]
15. [Susceptibility of Streptococcus pyogenes to penicillin, macrolides and clindamycin in Cádiz]. Marín P, Márquez A, García-Martos P, García-Tapia A, Tapia J. Rev Esp Quimioter; 2000 Sep 13; 13(3):318-9. PubMed ID: 11086284 [No Abstract] [Full Text] [Related]
16. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel. Sakran W, Raz R, Chazan B, Koren A, Colodner R. Int J Antimicrob Agents; 2004 May 13; 23(5):517-9. PubMed ID: 15120735 [Abstract] [Full Text] [Related]
17. [Biotypes and antimicrobial susceptibility of Streptococcus pyogenes strains isolated in children in Tunis]. Ksia S, Smaoui H, Hariga D, Kechrid A. Bull Soc Pathol Exot; 2010 May 13; 103(2):69-74. PubMed ID: 20390396 [No Abstract] [Full Text] [Related]
18. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides]. Sakran W, Raz R, Colodner R, Keness Y. Harefuah; 1997 Nov 02; 133(9):365-6, 414. PubMed ID: 9418339 [Abstract] [Full Text] [Related]
19. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci]. Kaya EG, Yücel M, Karakoç AE. Mikrobiyol Bul; 2006 Jul 02; 40(3):161-8. PubMed ID: 17001844 [Abstract] [Full Text] [Related]
20. [Sensitivity to beta lactams and macrolides of Streptococcus pyogenes isolated at the services from 1994 to 1998]. Nait-Kaci S, Boukarana W, Rahal K. Arch Inst Pasteur Alger; 1998 Jul 02; 62():13-23. PubMed ID: 11256303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]